vs
AURORA CANNABIS INC（ACB）与Cronos Group Inc.（CRON）财务数据对比。点击上方公司名可切换其他公司
Cronos Group Inc.的季度营收约是AURORA CANNABIS INC的472.8倍（$44.5M vs $94.2K）。AURORA CANNABIS INC净利率更高（-1.9% vs -4.1%，领先2.2%）
奥罗拉大麻公司是加拿大获得官方许可的大麻生产商，总部位于埃德蒙顿。截至2018年9月，公司拥有八家合规生产工厂、五张销售牌照，业务遍及全球25个国家，年大麻产能超62.5万公斤，核心产能布局在加拿大，同时在丹麦、拉美等国际市场积极拓展业务。
Cronos集团是全球性大麻素企业，主营大麻种植、加工及相关衍生产品的分销业务，产品线覆盖健康补充剂、快消品及医用大麻品类，主要服务北美、欧洲、亚太地区的合规娱乐与医用消费市场，严格遵循各地监管要求保障产品品质。
ACB vs CRON — 直观对比
营收规模更大
CRON
是对方的472.8倍
$94.2K
净利率更高
ACB
高出2.2%
-4.1%
损益表 — Q3 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $94.2K | $44.5M |
| 净利润 | $-1.7K | $-1.8M |
| 毛利率 | — | 36.4% |
| 营业利润率 | — | -16.8% |
| 净利率 | -1.9% | -4.1% |
| 营收同比 | — | 47.0% |
| 净利润同比 | — | -104.2% |
| 每股收益（稀释后） | — | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACBCRON
| Q4 25 | $94.2K | $44.5M | ||
| Q3 25 | — | $36.3M | ||
| Q2 25 | — | $33.5M | ||
| Q1 25 | $90.5K | $32.3M | ||
| Q4 24 | — | $30.3M | ||
| Q3 24 | — | $34.3M | ||
| Q2 24 | — | $27.8M | ||
| Q1 24 | $45.6K | $25.3M |
净利润ACBCRON
| Q4 25 | $-1.7K | $-1.8M | ||
| Q3 25 | — | $26.0M | ||
| Q2 25 | — | $-39.7M | ||
| Q1 25 | — | $6.1M | ||
| Q4 24 | — | $43.7M | ||
| Q3 24 | — | $8.3M | ||
| Q2 24 | — | $-8.8M | ||
| Q1 24 | — | $-2.2M |
毛利率ACBCRON
| Q4 25 | — | 36.4% | ||
| Q3 25 | — | 50.4% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 42.6% | ||
| Q4 24 | — | 35.7% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 22.7% | ||
| Q1 24 | 54.0% | 17.7% |
营业利润率ACBCRON
| Q4 25 | — | -16.8% | ||
| Q3 25 | — | -1.4% | ||
| Q2 25 | — | -15.9% | ||
| Q1 25 | — | -12.6% | ||
| Q4 24 | — | -37.5% | ||
| Q3 24 | — | -98.2% | ||
| Q2 24 | — | -56.1% | ||
| Q1 24 | — | -63.1% |
净利率ACBCRON
| Q4 25 | -1.9% | -4.1% | ||
| Q3 25 | — | 71.4% | ||
| Q2 25 | — | -118.7% | ||
| Q1 25 | — | 19.0% | ||
| Q4 24 | — | 144.3% | ||
| Q3 24 | — | 24.4% | ||
| Q2 24 | — | -31.5% | ||
| Q1 24 | — | -8.9% |
每股收益（稀释后）ACBCRON
| Q4 25 | — | $-0.01 | ||
| Q3 25 | — | $0.07 | ||
| Q2 25 | — | $-0.10 | ||
| Q1 25 | — | $0.02 | ||
| Q4 24 | — | $0.12 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | — | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $831.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $1.1B |
| 总资产 | — | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACBCRON
| Q4 25 | — | $831.8M | ||
| Q3 25 | — | $824.2M | ||
| Q2 25 | — | $834.4M | ||
| Q1 25 | — | $837.8M | ||
| Q4 24 | — | $858.8M | ||
| Q3 24 | — | $862.0M | ||
| Q2 24 | — | $848.2M | ||
| Q1 24 | — | $855.1M |
股东权益ACBCRON
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
总资产ACBCRON
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $11.8M |
| 自由现金流经营现金流 - 资本支出 | — | $9.7M |
| 自由现金流率自由现金流/营收 | — | 21.8% |
| 资本支出强度资本支出/营收 | — | 4.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $149.0K |
8季度趋势，按日历期对齐
经营现金流ACBCRON
| Q4 25 | — | $11.8M | ||
| Q3 25 | — | $13.3M | ||
| Q2 25 | — | $2.8M | ||
| Q1 25 | — | $-2.1M | ||
| Q4 24 | — | $7.7M | ||
| Q3 24 | — | $11.6M | ||
| Q2 24 | — | $1.7M | ||
| Q1 24 | — | $-2.2M |
自由现金流ACBCRON
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-17.4M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | — | $5.2M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | $-3.9M |
自由现金流率ACBCRON
| Q4 25 | — | 21.8% | ||
| Q3 25 | — | 24.3% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | — | -53.8% | ||
| Q4 24 | — | 13.8% | ||
| Q3 24 | — | 15.1% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | -15.5% |
资本支出强度ACBCRON
| Q4 25 | — | 4.8% | ||
| Q3 25 | — | 12.3% | ||
| Q2 25 | — | 11.5% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | — | 18.7% | ||
| Q2 24 | — | 2.6% | ||
| Q1 24 | — | 6.8% |
现金转化率ACBCRON
| Q4 25 | — | — | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.34× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 1.39× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACB
暂无分部数据
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
